Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.

Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis retrieved 18 March 2024 from https://medicalxpress.com/news/2024-03-trials-bimekizumab-response-durable-years.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Mar 15, 2024 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The American Academy Of Orthopaedic Surgeons annual meetingThe annual meeting of the American Academy of Orthopaedic Surgeons was held from Feb. 12 to 16 in San Francisco and attracted approximately 30,000 participants from around the world.
Source: medical_xpress - 🏆 101. / 51 Read more »

Study highlights potential of p-tau217 assays in Alzheimer's clinical trials and diagnosisThe performance of two commercial phospho-tau217 (p-tau217) assays.
Source: NewsMedical - 🏆 19. / 71 Read more »

Glen Sannox sea trials 'overwhelmingly positive'One of the delayed ferries being built at Ferguson shipyard performs well under its own power for the first time.
Source: BBCWestScot - 🏆 85. / 53 Read more »

The Outlast Trials outlines post-launch plans with this intriguing Q&A sessionWhen​ ​her friends​ ​were falling in love with soap stars, Vikki was falling in love with​ ​video games. She's a survival horror survivalist​ ​with a penchant for​ ​Yorkshire Tea, men dressed up as doctors and sweary words. She struggles to juggle a fair-to-middling Destiny/Halo addiction​ ​and her kill/death ratio is terrible.
Source: eurogamer - 🏆 68. / 61 Read more »

‘Oppenheimer' wins best picture and ‘Barbie' dazzles on stage at 96th Academy AwardsChristopher Nolan's 'Oppenheimer' won seven Academy Awards Sunday night, including best picture, best actor for Cillian Murphy and best supporting actor for…
Source: NECN - 🏆 20. / 71 Read more »

Oscars 2024: Full List Of Winners From This Year's Academy AwardsDayna McAlpine is HuffPost UK's Senior Entertainment and Life Editor. She covers everything from sex, relationships and dating to health, travel and shopping as well as reporting on the latest showbiz, TV and celeb news.
Source: HuffPostUK - 🏆 108. / 51 Read more »